Work

A First-in-human Phase I Study Demonstrating Safety, Tolerability, And Preliminary Efficacy Of RP-A601, An AAV-mediated Gene Therapy (AAVrh.74-PKP2a) In Adult Patients With PKP2-arrhythmogenic Cardiomyopathy (PKP2-ACM)

Year: 2026

Type: article

Study design: Clinical Trial

Source: Journal of Cardiac Failure

DOI: 10.1016/j.cardfail.2025.11.065

Authors: Barry Greenberg, Cameron Olandt, Matthew Coggins, David Ricks, Noor Hasan, Susanna Carou-Keenan, Lily Ding, Kinnari Patel, Jonathan D. Schwartz, Quan M. Bui, Kimberly N. Hong

Institutions: University of California San Diego, Cranberry Institute

Language: English

Topic: Cardiovascular Effects of Exercise

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7123347916

FWCI: 4.824

Cites:

Cited by: 1

Related to: